0001437749-13-008385.txt : 20130702 0001437749-13-008385.hdr.sgml : 20130702 20130702174722 ACCESSION NUMBER: 0001437749-13-008385 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20130630 FILED AS OF DATE: 20130702 DATE AS OF CHANGE: 20130702 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Furiex Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0001484478 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 271197863 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 3900 PARAMOUNT PARKWAY STREET 2: SUITE 150 CITY: MORRISVILLE STATE: NC ZIP: 27560 BUSINESS PHONE: 919-456-7800 MAIL ADDRESS: STREET 1: 3900 PARAMOUNT PARKWAY STREET 2: SUITE 150 CITY: MORRISVILLE STATE: NC ZIP: 27560 FORMER COMPANY: FORMER CONFORMED NAME: PPD Therapeutics, Inc. DATE OF NAME CHANGE: 20100218 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: ESHELMAN FREDRIC N CENTRAL INDEX KEY: 0001033409 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-34641 FILM NUMBER: 13950111 MAIL ADDRESS: STREET 1: PPD INC STREET 2: 929 NORTH FRONT STREET CITY: WILMINGTON STATE: NC ZIP: 28401 4 1 rdgdoc.xml PRIMARY DOCUMENT X0306 4 2013-06-30 0001484478 Furiex Pharmaceuticals, Inc. FURX 0001033409 ESHELMAN FREDRIC N C/O FURIEX PHARMACEUTICALS, INC., 3900 PARAMOUNT PARKWAY, SUITE 150 MORRISVILLE NC 27560 1 1 Common Stock 2013-06-30 4 A 0 7161 0 A 2673522 D Common Stock 132689 I LLC Common Stock 41666 I GRAT Common Stock 140 I Spouse Stock Options (to buy) 9.11 2020-06-17 Common Stock 65876 65876 I LLC Stock Options (to buy) 13.16 2021-10-03 Common Stock 98813 98813 I LLC The restricted stock was awarded on 6/30/2013 and vests in its entirety on the earlier of 5/24/2014 or immediately prior to the 2014 Annual Stockholder meeting, provided that the Grantee is still at that time serving on the Company's Board of Directors. The options were awarded on 6/17/2010 and vest over three years, with one-third of the options vesting on each of the first, second and third anniversaries of the date of grant, provided the Optionee's consulting relationship continues. The options were awarded on 10/3/2011 and vest over three years, with one-third of the options vesting on each of the first, second and third anniversaries of the date of grant, provided the Optionee's consulting relationship continues. /s/ Donald R. Reynolds, by Power of Attorney 2013-07-02